Clinical Trial Update: System-IGF-1 Pathway and Alzheimer's Disease

View source ↗

Summary

Completion of a clinical trial evaluating the System-IGF-1 pathway in Alzheimer's disease and mild cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Alzheimer's Disease, Mild Cognitive Impairment | Status: COMPLETED